Detection of Chromosomal Aberrations in Prostate Cancer by Fluorescence in Situ Hybridization (FISH)

European Urology

Volumn 44, Issue 6, 2003, Pages 666-671

  Celep, Figen ^a   Karagüzel, Ahmet ^a   Özgür, Güner K ^a   Yildiz, Kadriye ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Fluorescence in situ hybridization (FISH); Prostatic carcinoma; Tissue culture

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; CHROMOSOME 10; CHROMOSOME 17; CHROMOSOME 7; CHROMOSOME 8; CHROMOSOME 9; CHROMOSOME ABERRATION; CLINICAL ARTICLE; DNA PROBE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MALE GENITAL TRACT CANCER; MONOSOMY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; TISSUE CULTURE; TRANSURETHRAL RESECTION; X CHROMOSOME; Y CHROMOSOME;

EID: 0348165955     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0302-2838(03)00414-7     Document Type: Article

References (37)

1. Lundgren R, Heim S, Mandahl N, Anderson H, Mitelman F. Chromosome abnormalities are associated with unfavorable outcome in prostate cancer patients. J Urol 1992;147:784-8.
2. Oba K, Matsuyama H, Yoshihiro S, Kishi F, Takahashi M, Tsukamoto M, et al. Two putative tumor supressor genes on chromosome arm 8p may play different roles in prostate cancer. Cancer Genet Cytogenet 2001;124:20-4.
3. Steilen H, Ketter R, Romanakis K, Zwergel T, Unteregger G, Bonkhoff H, et al. DNA aneuploidy in prostatic adenocarcinoma: a frequent event as shown by fluorescence in situ hybridization. Hum Pathol 1994;25:1306-13.
4. Brothman AR, Watson MJ, Zhu XL, Williams BJ, Rohr LR. Evaluation of 20 archival prostate tumor specimens by fluorescence in situ hybridization (FISH). Cancer Genet Cytogenet 1994;75: 40-4.
5. Schaid DJ, McDonnell SK, Blute ML, Thibadeau SN. Evidence for autosomal dominant inheritance of Prostate cancer. Am J Hum Genet 1998;62:1425-38.
6. Kallioniemi OP, Visakorpi T. Genetic basis and clonal evolution of human prostate cancer. Adv Cancer Res 1996;68:225-55.
7. Nupponen NN, Visakorpi T. Molecular cytogenetics of prostate cancer. Microsc Res Tech 2000;51:456-63.
8. Forozan F, Karhu R, Kanonen J, Kallioniemi A, Kallioniemi OP. Genome screening by comparative genomic hybridization. Trends Genet 1997;13:405-9.
9. Sandberg AA. Chromosomal abnormalities and related events in prostate cancer. Hum Pathol 1992;23:368-80.
10. Brothman AR, Maxwell TM, Cui J, Deubler DA, Zhu XL. Chromosomal clues to the development of prostate tumours. Prostate 1999;38:303-12.
11. Breitkreuz T, Romanakis K, Lutz S, Seitz G, Bonkhoff H, Unteregger G, et al. Genotypic characterization of prostatic carcinomas: a combined cytogenetic, flow cytometry, and in situ DNA hybridization study. Cancer Res 1993;53:4035-40.
12. Henke RP, Krüger E, Ayhan N, Hübner D, Hammerer P. Numerical chromosomal aberrations in prostate cancer: correlation with morphology and cell kinetics. Virchows Archiv A Pathol Anat 1993;422:61-6.
13. Peehl DM, Stamey TA. Serum-free growth of adult human prostatic epithelial cells. In vitro Cellular Develop Biol 1986;22:82-90.
14. Micale MA, Mohammed A, Sakr W, Powell IJ, Wolman SR. Cytogenetics of primary adenocarcinoma: clonality and chromosome instability. Cancer Genet Cytogenet 1992;61:165-73.
15. Trask B. FISH: Applications in cytogenetics and gene mapping. Tech Focus 1991;7:149-54.
16. Lichter P. Multicolor FISHing: what's the catch? Trends Genet 1997;13(12):475-9.
17. Wolman SR. Applications of fluorescence in situ hybridization techniques in cytopathology. Cancer (Cancer Cytopathology) 1997: 193-7.
18. Bontron D, FitzPatrick D, Porteus M, Trainer A. Clinical Genetics. A Case-Based Approach. London: W.B. Saunders; 1998. p. 34-6.
19. Pinkel D, Straume T, Gray JW. Cytogenetic analysis using quantative, high-sensitivity, fluorescence hybridization. Proc Natl Acad Sci USA 1986;83:2934-8.
20. Hopman AHN, Ramaekers FCS, Raap AK, Beck JLM, Devilee P, van der Ploeg M, et al. In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder tumors. Histochemistry 1988;89:307-16.
21. Matsuura H, Shiraishi T, Yatani R, Kawamura J. Interphase cytogenetics of prostate cancer: fluorescence in situ hybridization (FISH) analysis of Japanese cases. Br J Cancer 1996;74:1699-704.
22. Yan J, Guilbault E, Masse J, Bronsard M, DeGrandpre P, Forest JC, et al. Optimization of the FISH technique for high detection efficiency of very small proportions of target interphase nuclei. Clin Genet 2000;58:309-18.
23. Poddighe PJ, Ramaekers FCS, Hopman AHN. Interphase cytogenetics of tumours. J Pathol 1991;166:215-24.
24. Heiskanen M, Peltonen L. Palotie A. Visual mapping by high resolution FISH. Trends Genet 1996;12(10):379-82.
25. Klinger KW. FISH: sensitivity and specifity on sorted and unsorted cells. Ann NY Acad Sci 1994;731:48-56.
26. Persons DL, Gibney DJ, Katzmann JA, Lieber MM, Farrow GM, Jenkins RB. Use of Fluorescence In Situ Hybridization for deoxyribonucleic acid ploidy analysis of prostatic adenocarcinoma. J Urol 1993;150:120-5.
27. Gleason DF, Veeterans Administration Cooperative Urological Research Group. Histologic grading and clinical staging of prostate carcinoma. In: Tannenbaum M, editor. Urologic pathology: the prostate. Philadelphia: Lea and Febiger; 1974. p. 171-97.
28. Konig JJ, Teubel W, VanDongen JW, Romijn JC, Hagemeijer A, Schronder FH. Loss and gain of chromosomes 1, 18, and Y in prostate cancer. Prostate 1994;25:281-91.
29. Teixera MR, Wehre H, Ragnhild AL, Stenwig AE, Pandis N, Giercksky KE, et al. High frequency of clonal chromosome abnormalities in prostatic neoplasms sampled by prostatectomy or ultrasound-guided needle biopsy. Genes Chrom Cancer 2000;28: 211-9.
30. McCahy PJ, Harris CA, Neal DE. Breast and prostate cancer in the relatives of men with prostate cancer. Br J Urol 1996;78:552-6.
31. Arps S, Rodewald A, Schmalenberger B, Carl P, Bressel M, Kastendieck H. Cytogenetic survey of 32 cancers of the prostate. Cancer Genet Cytogenet 1993;66:93-9.
32. Macoska JA, Micale MA, Sakr WA, Benson PD, Wolman SR. Extensive genetic alterations in prostate cancer revealed by dual PCR and FISH analysis. Genes Chrom Cancer 1993;8:88.
33. Cher MI, Ito T, Weidner N, Carroll PR, Jensen RH. Mapping of regions of physical deletion on chromosome 16q in prostate cancer cells by FISH. J Urol 1995;153:249-54.
34. Brown JA, Alcaraz A, Takahashi S, Persons DL, Lieber MM, Jenkins RB. Chromosomal aneusomies detected by fluorescence in situ hybridization analysis in clinically localized prostate carcinoma. J Urol 1994;152:1157-62.
35. Johansson B, Heim S, Mandahl N, Mertens F, Mitelman F. Trisomy 7 in nonneoplastic cells. Genes Chrom Cancer 1993;6:199-205.
36. Bandyk MG, Zhao L, Troncoso P, Pisters LL, Palmer JL, Von Eschenbach AC, et al. Trisomy 7: a potential cytogenetic marker of human prostate cancer progression. Genes Chromosomes Cancer 1994;9:19-27.
37. Jordan JJ, Hanlan AL, Al-Saleem TI, Greenberg RE, Tricoli JV. Loss of the short arm of the Y chromosome in human prostate carcinoma. Cancer Genet Cytogenet 2001;124:122-6.